MktsMarkets

Roivant Sciences Ltd.
NASDAQ: ROIVKey statistics
ROIV News
Stories mentioning ROIV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 2,520 | 1,999 | 1,571 | 2,170 | 7,570 | 9,018 | 4,475 | 7,990 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 198,945 | 165,380 | 164,568 | 152,919 | 145,238 | 141,595 | 143,073 | 120,507 |
| Sales General & Admin | 148,519 | |||||||
| Total Operating Expenses | 357,515 | 341,152 | 307,804 | 287,092 | 292,535 | 283,399 | 346,188 | 220,612 |
| Operating Income (Loss) | 415,240 | (339,153) | (306,233) | (284,922) | (284,965) | (274,381) | (341,713) | (102,235) |
| Interest Income | 43,266 | 45,341 | 61,851 | 69,773 | ||||
| Interest Expense | 13,399 | |||||||
| Other Expense | 12,572 | 8,342 | (5,694) | (11,208) | (2,844) | (2,816) | (1,453) | (3,608) |
| Pretax Income | 454,097 | (290,369) | (159,044) | (269,262) | (203,054) | (234,513) | (224,383) | (19,640) |
| Tax Provision | 98,353 | 23,332 | 6,995 | 4,649 | 49,321 | (25,568) | 12,458 | 11,963 |
| Net Income (Loss) | 302,994 | (265,891) | (113,519) | (223,355) | (206,475) | 169,381 | (230,184) | 95,297 |
| Earnings Per Share (Basic) | 0.44 | (0.38) | (0.17) | (0.33) | (0.28) | 0.23 | (0.31) | 0.13 |
| Earnings Per Share (Diluted) | 0.44 | (0.38) | (0.17) | (0.33) | (0.28) | 0.23 | (0.31) | 0.12 |
| Weighted Average Shares Outstanding (Basic) | 693,865 | 696,860 | 680,948 | 680,287 | 725,396 | 722,716 | 735,471 | 735,817 |
| Weighted Average Shares Outstanding (Diluted) | 693,865 | 696,860 | 680,948 | 680,287 | 725,396 | 722,716 | 735,471 | 781,628 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ROIV
Roivant Sciences Ltd. (NASDAQ: ROIV) is a stock listed on the Nasdaq Stock Market under the ticker symbol ROIV. It last traded at $40.67 (Nov 9, 2026, 9:30 AM ET), up 4.6% on the day. That gives Roivant Sciences a market capitalisation of $24.2B.
Over the past 52 weeks ROIV has traded between $19.79 and $42.50.
Revenue for the quarter ended Mar 31, 2026 was $2.5M; net income $303.0M. Revenue was down 66.7% from $7.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $2.5M | $303.0M | 12023.6% |
| Dec 31, 2025 | $2.0M | -$265.9M | -13301.2% |
| Sep 30, 2025 | $1.6M | -$113.5M | -7225.9% |
| Jun 30, 2025 | $2.2M | -$223.4M | -10292.9% |
From Roivant Sciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…